(PharmaNewsWire.Com, January 07, 2017 ) Fractional Flow Reserve Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years and discussion of the key vendors effective in this market. To calculate the market size, the report considers the revenue generated from the sales of Fractional Flow Reserve globally.
The Fractional Flow Reserve Market report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
Following Companies Are Key Players of the Fractional Flow Reserve Market:
ACIST Boston Scientific Opsens St. Jude Medical
Other Prominent Vendors of Fractional Flow Reserve Market Are:
Abbott Laboratories Asahi Intec Biosensors BIOTRONIK international GE Healthcare
: “A trend which is propelling market growth is the rising number of clinical trials and regulatory approvals. There has been a growing trend of clinical trials and regulatory approvals in the market. With the growing demand for fractional flow reserve technology, the new companies are continuously seeking ways to gain approvals and launch new products in the market to improve their market share. In January 2014, ACIST's RXi received 510(k) FDA approval for use in gaining intravascular pressure measurements in the diagnosis and treatment of peripheral artery disease and CAD.”
According to the Fractional Flow Reserve Market report, a key growth driver is the increased need for diagnosis of coronary artery diseases (CAD). There has been an increased need for a suitable procedure to diagnose the growing prevalence of CAD. Coronary angiography is the standard procedure used for diagnosis of CAD. However, the standard coronary angiography with visual assessment and quantitative coronary angiography alone cannot accurately predict the exact lesion that is causing ischemia. These methods may not provide the clear picture about the severity and hemodynamic significance of lesions. Several studies state that the coronary angiogram is limited and does not measure the extent to which a stenosis is hampering the blood flow. Therefore, the demand for new diagnosis techniques such as fractional flow reserve has increased.
Report also presents Geographical Segmentation analysis of Fractional Flow Reserve Market of Americas, APAC, EMEA region.
Further, the Fractional Flow Reserve Market report states that one challenge that could impact market growth adversely is the stringent regulatory environment.
Key questions answered in Fractional Flow Reserve market report:
What will the Fractional Flow Reserve market size be in 2020 and what will the growth rate be? What are the key market trends? What is driving Fractional Flow Reserve market? What are the challenges to Fractional Flow Reserve market growth? Who are the key vendors in Fractional Flow Reserve market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Market Reports World is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
